286,325 page views of this website between February 1st 2018 and 31st January 2019.
42,687 key individuals such as policymakers and academics throughout the EU and the rest of the world currently receive this publication.
To verify the above or to gain more detailed statistics please contact Stephanie Davies, our Head of Operations.

EU HEALTHCARE & SOCIAL CARE NEWS

Artificially sweetened beverages could cause stroke in post-menopausal women

Artificially sweetened beverages could cause stroke in post-menopausal women

Among post-menopausal women, drinking multiple artificially sweetened beverages daily was associated with an increase in the risk of having a stroke. According to research published...
New research indicates that physiological age is better at predicting death

New research indicates that physiological age is better at predicting death

Published in the European Journal of Preventive Cardiology, research says predicting death does not necessarily come down to how old you are, it comes...
Hospitals joining forces to achieve healthcare solutions

Hospitals joining forces to achieve healthcare solutions

Royal Marsden and University College London, UK, partner with Hyland Healthcare as hospitals seek healthcare solutions to provide comprehensive patient insight. Two UK hospital trusts...
Brexit: Is there a Doctor in the House?

Brexit: Is there a doctor in the house?

The media has been bombarded by the polarising Brexit ‘debate’, but the reality is that Brexit is happening with or without your support, and...
Cannabis-based medicine to be tested in Azheimer’s trial

Cannabis-based medicine to be tested in Azheimer’s trial

Alzheimer’s Research UK is committing nearly £300,000 (~€341,000) for a landmark phase II clinical trial of Sativex®, a cannabis-based medicine licensed in the UK. The...
In depth: Canada’s landmark Cannabis Act

In depth: Canada’s landmark Cannabis Act

Health Europa examines how the Cannabis Act, which came into force in October 2018, will operate alongside Canada’s existing medical cannabis framework. The Cannabis Act...
Treating opioid addiction may be harder than you think

Treating opioid addiction may be harder than you think

OHSU study finds it's easy to get opioids but increasingly difficult to get medical assisted help when it comes to treating opioid addiction. According to...
MCSS: the digital transformation of medication handling

MCSS: the digital transformation of medication handling

CEO Ulrika Kjellberg tells Health Europa more about how the medication handling has transformed nursing home and residential care in Sweden. Appva’s fully digital Medication...
Could human gut bacterium reveal possible connection to depression

Could human gut bacterium reveal possible connection to depression?

Researchers have established a correlation between depression and a group of neurotransmitter-producing bacteria found in human gut bacterium. From the U.S. Department of Energy's (DOE)...
Dementia Consortium welcomes £9.5 million dementia drug discovery collab

Dementia Consortium welcomes £9.5 million dementia drug discovery collab

The Dementia Consortium welcomes Johnson & Johnson Innovation, Takeda and Evotec to join the unique £9.5 million (~€10.85m) charity-industry dementia drug discovery collaboration. This second...

Latest Publication

Health Europa Quarterly Issue 08

Discover the evolving world of healthcare, as Health Europa Quarterly issue 08 probes the environment of rare, infectious and chronic diseases and explores the...

Event Partners

EVENT PARTNERS

LATEST HEALTH EBOOKS

TILRAY: the medical cannabis research global leader

Medical cannabis is rapidly gaining momentum across the globe, and Tilray Inc. is pioneering the production, research, and distribution of medical cannabis. This ebook explores...

Understanding mucopolysaccharide storage diseases

What are mucopolysaccharide storage diseases? What are their signs and symptoms? And what treatment options are available for patients? These are just some of the...

Institute for Cardiogenetics – unravelling the genetics of cardiovascular disease

Cardiovascular disease (CVD) is a major global killer, but little is known about the exact causes. The Institute for Cardiogenetics aims to understand the...

The MPS Society: supporting those with mucopolysaccharidoses

Being diagnosed and living with mucopolysaccharidoses is life changing. The Austrian MPS Society, MPS Austria, is an organisation which supports families and their individuals...

LATEST PARTNERS

Addressing unmet clinical needs in burns and trauma by developing personalised...

CUTISS AG is at the forefront of innovation in developing personalised skin solutions to the clinical problem of scar tissue and its development. Scarring can...

Research advances in medicine and biotechnology

Center for Applied Biotechnology and Molecular Medicine (CABMM) The Center for Applied Biotechnology and Molecular Medicine (CABMM) is an official competence centre of the University...

Center for Vaccine Research

The Center for Vaccine Research is an integral part of Statens Serum Institut (SSI), which is under the auspices of the Danish Ministry of...

How medicine can prevent the recurrence of cancer and Innocent inspiration

Active in scientific research  for more than 30 years, Professor Michael Lisanti began his education in medicine at New York University, US, graduating Magna...

Pin It on Pinterest